Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China: a multicentre, retrospective cohort study

Author:

Han Xiaobo12,Li Chenglong34,Yuan Xin5,Cui Junchang12,Han Zhihai6,Meng Jiguang78,Zhao Weiguo1,Xie Fei9,Wang Kaifei9,Liu Yuhong1,Muo Guoxin1,Xi Na10,Zheng Mengli12,Wang Rentao12,Xiao Kun12,Chen Wei6,Xiong Junchen67,Zhao Dahui9,Zhang Xinxin1,Han Xinjie1,Cheng Haibo11,Yu Zhongkuo12,Shi Yinghan12,Xie Wuxiang1213,Xie Lixin12

Affiliation:

1. College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China

2. Chinese PLA Medical School, Beijing, China

3. National Institute of Health Data Science, Peking University, Beijing, China

4. Institute of Medical Technology, Health Science Center of Peking University, Beijing, China

5. Pulmonary and Critical Care Medicine Department, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China

6. Pulmonary and Critical Care Medicine Department, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China

7. Pulmonary and Critical Care Medicine Department, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China

8. Naval Clinical College, Anhui Medical University, Hefei, China

9. Pulmonary and Critical Care Medicine Department, The First Medical Center, Chinese PLA General Hospital, Beijing, China

10. Pharmacy Department, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China

11. Shandong Future Network Research Institute, Jiangsu Future Network Group Co., Ltd., Jiangsu, China

12. Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China

13. Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China

Funder

The Ethics Committee of Chinese PLA General Hospital

China National Natural Science Foundation

Publisher

Informa UK Limited

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3